Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1987
Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group StudyD S Alberts, R Kronmal, L H Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613)L H Baker, J Frank, G Fine, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Cancer|November 15, 1983
Treatment of six cases of mesothelioma with doxorubicin and cisplatinB L Zidar, R P Pugh, L M Schiffer, et al.
Cancer|November 1, 1984
Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group studyJ P Hester, C C Waddell, C A Coltman, et al.
Cytometry|November 1, 1993
Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasmsM M Zalupski, J R Ryan, J F Ensley, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group studyG Weiss, S Green, D S Alberts, et al.
Investigational New Drugs|January 1, 1996
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeksB J Foster, P M LoRusso, E Poplin, et al.
Cancer Treatment Reports|January 1, 1980
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomasB S Yap, L H Baker, J G Sinkovics, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Pageof 13